Results 161 to 170 of about 417,892 (210)
Some of the next articles are maybe not open access.
2006
Abstract The pharmaceutical industry produces a great number of new products each year, and it is crucial that prescribers be informed about the innovations on a continuing basis. This activity is marketing. According to a report by the Pharmaceutical Research and Manufacturers of America (PhRMA) (2002a, 2002b), formerly the ...
openaire +1 more source
Abstract The pharmaceutical industry produces a great number of new products each year, and it is crucial that prescribers be informed about the innovations on a continuing basis. This activity is marketing. According to a report by the Pharmaceutical Research and Manufacturers of America (PhRMA) (2002a, 2002b), formerly the ...
openaire +1 more source
PharmacoEconomics, 1996
The National Health Service (NHS) accounts for more than 98% of the UK prescription medicines market, which is the sixth largest pharmaceutical market in the world. Most of this market is driven by the UK's approximately 35,000 general practitioners (GPs). It is an open market, with most leading foreign pharmaceutical companies having a strong presence.
openaire +2 more sources
The National Health Service (NHS) accounts for more than 98% of the UK prescription medicines market, which is the sixth largest pharmaceutical market in the world. Most of this market is driven by the UK's approximately 35,000 general practitioners (GPs). It is an open market, with most leading foreign pharmaceutical companies having a strong presence.
openaire +2 more sources
2018
The pharmaceutical industry has been heavily criticized for the amount it spends, as well as for the tactics it uses to promote drugs. This chapter begins by providing an overview of pharmaceutical promotion in recent years, and then offers a closer examination of each major promotional channel, including detailing, free samples, journal advertising ...
Stuart O. Schweitzer, Z. John Lu
openaire +1 more source
The pharmaceutical industry has been heavily criticized for the amount it spends, as well as for the tactics it uses to promote drugs. This chapter begins by providing an overview of pharmaceutical promotion in recent years, and then offers a closer examination of each major promotional channel, including detailing, free samples, journal advertising ...
Stuart O. Schweitzer, Z. John Lu
openaire +1 more source
An overview of the Greek pharmaceutical market
The European Journal of Health Economics, 2003This contribution presents the major aspects of the pharmaceutical market in Greece. Total expenditure on pharmaceuticals rose from euro 1.22 billion in 1995 to euro 1.85 billion in 2000. The rise in pharmaceutical expenditure is expected to continue due to factors determining demand (e.g., aging population) and deficiencies in public policy.
V, Kontozamanis +2 more
openaire +2 more sources
Journal of Pharmaceutical Finance, Economics & Policy, 2004
Pharmaceutical sales representatives provide useful information about products, but they have incentives to be overly positive. The literature written by physicians about pharmaceutical marketing and promotion generally focuses on the harmful aspects of promotion, and misses the benefits.
openaire +1 more source
Pharmaceutical sales representatives provide useful information about products, but they have incentives to be overly positive. The literature written by physicians about pharmaceutical marketing and promotion generally focuses on the harmful aspects of promotion, and misses the benefits.
openaire +1 more source
DEFINING RELEVANT MARKETS FOR PHARMACEUTICALS
Bulletin of Economic Research, 2016ABSTRACTTo identify the relevant product markets for Swedish pharmaceuticals, a spatial econometrics approach is employed. First, we calculate Moran's Is for different market definitions and then we use a spatial Durbin model to determine the effect of price changes on quantity sold of own and competing products.
Mihaescu, Oana, Rudholm, Niklas
openaire +2 more sources
The role and value of pharmaceutical marketing
Archives of Family Medicine, 1994Pharmaceutical marketing is the last element of an information continuum, where research concepts are transformed into practical therapeutic tools and where information is progressively layered and made more useful to the health care system. Thus, transfer of information to physicians through marketing is a crucial element of pharmaceutical innovation.
openaire +2 more sources
Market incentives and pharmaceutical innovation
Journal of Health Economics, 2008I study the impact of the Orphan Drug Act (ODA), which established tax incentives for rare disease drug development. I examine the flow of new clinical drug trials for a large set of rare diseases. Among more prevalent rare diseases, the ODA led to a significant and sustained increase in new trials.
openaire +2 more sources
An Information Infrastructure For The Pharmaceutical Market
Health Affairs, 2004The primary contribution of Joseph Newhouse's paper is to make the point that it is impossible to devise a drug pricing policy that satisfies either the conditions for economic efficiency or prevailing standards of "fairness." Not specifically mentioned by Newhouse is a rule for the socially efficient outlays on selling and marketing by the ...
openaire +2 more sources
Dilemmas In Regulation Of The Market For Pharmaceuticals
Health Affairs, 2003What can be learned from international experience of efforts to control spending and to improve efficiency and access in pharmaceutical markets? Policymakers tend to reinvent many policies to control the behavior of patients, doctors, and industry, despite a lack of evidence of those policies' cost-effectiveness.
Alan, Maynard, Karen, Bloor
openaire +2 more sources